1. Free normetadrenaline concentrations in plasma of patients with phaeochromocytoma were elevated 20-1000-fold as compared with values in primary hypertensive subjects.
Introduction
The diagnosis of phaeochromocytoma remains difficult in some patients, even after careful biochemical evaluation. The determination of normetadrenaline, the major 0-Correspondence: Dr Vincent DeQuattro, USC School of Medicine, 2025 Zonal Avenue, Los Angeles, California 90033, U.S.A. methylated metabolite of noradrenaline, in plasma could aid in the diagnosis of phaeochromocytoma (Kobayashi, DeQuattro, Kolloch & Miano, 1980b) and in elucidating the pathophysiology of primary hypertension (Kobayashi, Kolloch, DeQuattro & Miano, 1979) . Furthermore, the measurement of normetadrenaline in spinal fluid and various regional sites may aid in the diagnosis and location respectively of these tumours. We describe herein the contents of free normetadrenaline, noradrenaline and adrenaline in spinal fluid and in plasma of patients with primary hypertension and others with phaeochromocytoma. Normetadrenaline was also determined in plasma obtained from various regional sites in the patients with phaeochromocytoma.
Methods
Ten patients with primary hypertension (age 21-53 years) and five patients with phaeochromocytoma, the latter cured by surgical removal of their tumours, were participants in this study.
All patients with primary hypertension (a means of three blood pressure measurements on separate days of greater than 140/95 mmHg) underwent extensive diagnostic tests, including timed intravenous pyelograms. Patients with cardiac or renal sequelae of hypertension were excluded. After signing an informed consent, approved by the Institutional Review Committee, the patient was admitted to the Clinical Research Center and underwent a series of tests over a 44-day period which on a constant 100 mmol of Na+/80 mmol of K+ diet. All patients with primary hypertension had either not taken any hypertensive agents or had them discontinued a 276s V. DeQuattro et al.
minimum of 10 days before the study. None was taking reserpine or guanethedine. Of the patients with phaechromocytoma, three were treated with phenoxybenzamine (10-30 mg), one with phenytoin (300 mg) and one with a-methyltyrosine (1 -0 g/day) duringthe period of the study.
On the third hospital day, after fasting overnight, the patients stood erect for 1 h and then lay supine for 1 h. Blood samples were taken for normetadrenaline and noradrenaline at the end of each hour. Spinal fluid was obtained in the lateral decubitus position after the supine blood sample was drawn. Specimens were preserved with EGTA and glutathione and stored at -2OOC. Normetadrenaline (Kobayashi et al., 1979) noradrenaline and adrenaline (Peuler & Johnson, 1977) were measured by radioenzymatic assays.
Results
The mean values of the spinal fluid normetadrenaline, noradrenaline and adrenaline concentrations are given, with the simultaneous plasma values, for the patients in Table 1 . In addition, the means of the percentages of the contents of the three amines in spinal fluid compared with plasma are given for the two groups of patients.
There was no overlap in the range of plasma normetadrenaline and noradrenaline contents and the percentage of plasma amines in spinal fluid. The means of the normetadrenaline and catecholamine contents in plasma were greater in phaeochromocytoma. The differences were significant for noradrenaline only (P < 0.05). On the other hand, the percentages of plasma amine contents in spinal fluid were lower in phaeochromocytoma (P < 0.001, P < 0.001 and P < 0.01 for normetadrenaline, noradrenaline and adrenaline respectively).
For patients with phaeochromocytoma, there were elevations of both plasma normetadrenaline and noradrenaline (ranges 2989-302 000 and 7005-1 2 1 000 ng/l respectively) in the veins draining the tumours. The maximum concentrations were in the left renal or left adrenal veins in two patients with left adrenal tumours and the maximum content was in the right adrenal vein or vena cava adjacent to the orifice of the right adrenal vein in the three patients with right adrenal tumours.
Discussion
Recently, using a sensitive enzymatic assay, we found that plasma normetadrenaline was a reliable marker of sympathetic nerve function in man (Kobayashi, DeQuattro, Bornheimer, Kolloch & Miano, 1980a) . Further, we reported evidence of increased sympathetic nerve activity in some patients with primary hypertension after finding increased levels of plasma normetadrenaline and normetadrenaline excretion in young patients with primary hypertension (Kobayashi et al., 1979; Kolloch, Kobayashi & DeQuattro, 1980 ). Normetadrenaline appears to enter plasma from the adrenal medulla and from the distal venous sites, the latter reflecting perhaps peripheral sympathetic neurotransmitter release and metabolism. The amine appears to be removed in part by the kidneys and liver (Kobayashi et al., 1980a) . This study demonstrated the utility of normetadrenaline measurements in plasma to confirm the clinical diagnosis of phaeochromocytoma. Assessment of its content in venous blood from various sites in the vena cava and from the adrenal veins was useful clinically in locating the tumours.
A relative blood-brain barrier to noradrenaline, adrenaline and normetadrenaline yields a lower percentage of amine in spinal fluid than in plasma in patients with phaeochromocytoma. This value may also be useful in establishing the Amines in spinalfluid andphaeochromocytoma 277s diagnosis of phaeochromocytoma. There was no overlap in the amounts of normetadrenaline in cerebrospinal fluid expressed as a percentage of the plasma level: patients with phaeochromocytoma, less than 16%, and those with primary hypertension, greater than 36%. Previously, we found that in normotensive subjects and patients with primary hypertension the content of spinal fluid noradrenaline is related to plasma noradrenaline concentration as well as diastolic and systolic blood pressures (Eide, Kolloch, DeQuattro, Miano, Dugger & Van der Meulen, 1979) . The present study demonstrates that central noradrenergic tone may be quantified in primary hypertension by measurement of spinal fluid normetadrenaline. Comparative studies of plasma and cerebrospinal fluid normetadrenaline concentrations in normotensive and hypertensive patients may shed further light on the pathogenesis of primary hypertension.
